Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05893940 · ClinicalTrials.gov registry record · NA

Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients

A NA study of Hematopoietic and Lymphoid System Neoplasm, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT05893940: Recruiting NA study of Hematopoietic and Lymphoid System Neoplasm, sponsored by Roswell Park Cancer Institute.

NCT05893940 is a NA study of Hematopoietic and Lymphoid System Neoplasm that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 75 participants, below the 1,356-participant average among 31 other Hematopoietic and Lymphoid System Neoplasm trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05893940, a NA study of Hematopoietic and Lymphoid System Neoplasm, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

This clinical trial tests the effect of low-intensity mechanical stimulation (LIMS) vibration therapy in patients with hematologic malignancies. Patients with hematologic malignancies often undergo a blood and/or bone marrow transplant (hematopoietic cell transplantation \[HCT\]) or cellular therapy. The LIMS board delivers vibrations through the bones that may stimulate bone growth and may also increase muscle activity and strength and may also increase T-cell activation in patients planning to undergo cellular therapy. LIMS vibration therapy may stop or reverse BMD loss and/or improve the development of T-cells in the body in patients with hematologic malignancies who are undergoing or may plan to undergo HCT or cellular therapies.

Primary Outcome

Will assess how much time and days use throughout study period

Interventions

  • PROCEDURE Biospecimen Collection
  • PROCEDURE Dual X-ray Absorptiometry
  • PROCEDURE Low Intensity Vibration Therapy

Study Locations (1)

New York

  • Roswell Park Comprehensive Cancer Center - Buffalo

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2023-08-14
Est. Completion 2026-09-01
Phase NA
Roswell Park Cancer Institute

365 total trials

What NCT05893940 shows while recruiting

NCT05893940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,356-participant average among 31 other Hematopoietic and Lymphoid System Neoplasm trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Hematopoietic and Lymphoid System Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.

NCT05893940 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05893940 about?

NCT05893940 is a clinical study titled "Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients". This clinical trial tests the effect of low-intensity mechanical stimulation (LIMS) vibration therapy in patients with hematologic malignancies. Patients with hematologic malignancies often undergo a blood and/or bone marrow transplant (hematopoietic cell transplantation \[HCT\]) or cellular therapy...

What is the current status of trial NCT05893940?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2023-08-14. Estimated completion is 2026-09-01.

What conditions does trial NCT05893940 study?

This clinical trial studies the following conditions: Hematopoietic and Lymphoid System Neoplasm.

What interventions are being tested in trial NCT05893940?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Dual X-ray Absorptiometry (PROCEDURE), Low Intensity Vibration Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT05893940?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05893940 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hematopoietic and Lymphoid System Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05893940's enrollment target sits among peer trials

75 23rd of 31 higher than 9 of 31 other Hematopoietic and Lymphoid System Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hematopoietic and Lymphoid System Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05893940, the US trial registry maintained by the National Library of Medicine. NCT05893940 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.